Structural Insight into the Mechanism of 4-Aminoquinolines Selectivity for the alpha2A-Adrenoceptor

BACKGROUND: α(2A)-adrenoceptor (AR) is a potential target for the treatment of degenerative diseases of the central nervous system, and α(2A)-AR agonists are effective drugs for this condition. However, the lack of high selectivity for α(2A)-AR subtype of traditional drugs greatly limits their clinic usage. METHODS: A series of homobivalent 4-aminoquinolines conjugated by two 4-aminoquinoline moieties via varying alkane linker length (C2-C12) were characterized for their affinities for each α(2)-AR subtype. Subsequently, docking, molecular dynamics and mutagenesis were applied to uncover the molecular mechanism. RESULTS: Most 4-aminoquinolines (4-aminoquinoline monomer, C2-C6, C8-C10) were selective for α(2A)-AR over α(2B)- and α(2C)-ARs. Besides, the affinities are of similar linker length-dependence for each α(2)-AR subtype. Among all the compounds tested, C10 has the highest affinity for α(2A)-AR (pKi=−7.45±0.62), which is 12-fold and 60-fold selective over α(2B)-AR and α(2C)-AR, respectively. Docking and molecular dynamics suggest that C10 simultaneously interacts with orthosteric and “allosteric” sites of the α(2A)-AR. The mutation of F205 decreases the affinity by 2-fold. The potential allosteric residues include S90, N93, E94 and W99. CONCLUSION: The specificity of C10 for the α(2A)-AR and the potential orthosteric and allosteric binding sites proposed in this study provide valuable guidance for the development of novel α(2A)-AR subtype selective compounds.